ALPN Stock Discussion

Alpine Immune Sciences, Inc. Description

Alpine Immune Sciences, Inc., a development-stage specialty pharmaceutical company, engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. It is developing ALPN-101, an ICOS/CD28 antagonist program for the treatment of inflammatory diseases. The company is based in Seattle, Washington.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Pharmaceutical Disease Immune System Immunotherapy Medication Treatment Of Cancer Immunotherapies Inflammatory Diseases Stage Specialty Pharmaceutical Inflammatory Disorders Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases

Technical Analysis for ALPN - Alpine Immune Sciences, Inc.
Recent ALPN News